Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2017 1
2018 2
2019 1
2020 3
2021 5
2022 5
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 infection in aplastic anemia.
Avenoso D, Marsh JCW, Potter V, Pagliuca A, Slade S, Dignan F, Tholouli E, Mittal S, Davis B, Tauro S, Kesse-Adu R, Griffin M, Payne E, Gandhi S, Kulasekararaj AG. Avenoso D, et al. Haematologica. 2022 Feb 1;107(2):541-543. doi: 10.3324/haematol.2021.279928. Haematologica. 2022. PMID: 34670361 Free PMC article. No abstract available.
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.
Penack O, Peczynski C, Boreland W, Lemaitre J, Afanasyeva K, Kornblit B, Jurado M, Martinez C, Natale A, Pérez-Simón JA, Brunello L, Avenoso D, Klein S, Ozkurt ZN, Herrera C, Wichert S, Chiusolo P, Gavriilaki E, Basak GW, Schoemans H, Koenecke C, Moiseev I, Peric Z. Penack O, et al. Among authors: avenoso d. Front Immunol. 2023 Dec 11;14:1283034. doi: 10.3389/fimmu.2023.1283034. eCollection 2023. Front Immunol. 2023. PMID: 38149251 Free PMC article.
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party.
Penack O, Peczynski C, Boreland W, Lemaitre J, Reinhardt HC, Afanasyeva K, Avenoso D, Holderried TAW, Kornblit BT, Gavriilaki E, Martinez C, Chiusolo P, Mico MC, Dagunet E, Wichert S, Ozdogu H, Piekarska A, Kinsella F, Basak GW, Schoemans H, Koenecke C, Moiseev I, Peric Z. Penack O, et al. Among authors: avenoso d. Bone Marrow Transplant. 2024 Mar;59(3):380-386. doi: 10.1038/s41409-023-02174-2. Epub 2024 Jan 6. Bone Marrow Transplant. 2024. PMID: 38184740 Free PMC article.
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study.
Rampotas A, Sockel K, Panitsas F, Theuser C, Bornhauser M, Hernani R, Hernandez-Boluda JC, Esquirol A, Avenoso D, Tsirigotis P, Robin M, Czerw T, Helbig G, Roddie C, Lambert J, McLornan DP. Rampotas A, et al. Among authors: avenoso d. Transplant Cell Ther. 2023 Nov;29(11):687.e1-687.e7. doi: 10.1016/j.jtct.2023.08.020. Epub 2023 Aug 24. Transplant Cell Ther. 2023. PMID: 37633414
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients.
Avenoso D, Mehra V, Slonim LB, de Farias M, Alshehri H, Bouziana S, Krishnamurthy P, Kulasekararaj A, Dazzi F, Wood H, Kenyon M, Leung YT, Anteh S, Shah MN, Hannah G, Serpenti F, Gameil A, Bourlon C, Dragoi OD, Pagliuca A, Potter V. Avenoso D, et al. Transplant Cell Ther. 2023 Nov;29(11):698.e1-698.e6. doi: 10.1016/j.jtct.2023.08.012. Epub 2023 Aug 12. Transplant Cell Ther. 2023. PMID: 37579918
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT.
Robin M, Iacobelli S, Koster L, Passweg J, Avenoso D, Wilson KMO, Salmenniemi U, Dreger P, von dem Borne P, Snowden JA, Robinson S, Finazzi MC, Schroeder T, Collin M, Eder M, Forcade E, Loschi M, Bramanti S, Pérez-Simón JA, Czerw T, Polverelli N, Drozd-Sokolowska J, Raj K, Hernández-Boluda JC, McLornan DP. Robin M, et al. Among authors: avenoso d. Bone Marrow Transplant. 2024 Mar 15. doi: 10.1038/s41409-024-02269-4. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38491198
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients.
Harrington P, Doores KJ, Saha C, Saunders J, Child F, Dillon R, Saglam S, Raj K, McLornan D, Avenoso D, Kordasti S, O'Reilly A, Espehana A, Lechmere T, Khan H, Malim MH, Harrison C, Mehra V, de Lavallade H. Harrington P, et al. Among authors: avenoso d. Cancer Cell. 2021 Nov 8;39(11):1448-1449. doi: 10.1016/j.ccell.2021.10.002. Epub 2021 Oct 12. Cancer Cell. 2021. PMID: 34717827 Free PMC article. No abstract available.
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure Lymphoma.
Avenoso D, Alabdulwahab A, Kenyon M, Mehra V, Krishnamurthy P, Dazzi F, Leung YT, Anteh S, Shah MN, Kuhnl A, Sanderson R, Patten P, Yallop D, Pagliuca A, Potter V. Avenoso D, et al. Mediterr J Hematol Infect Dis. 2023 Jul 1;15(1):e2023041. doi: 10.4084/MJHID.2023.041. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 37435036 Free PMC article.
25 results